Jennifer Nessel, Assistant Editor

Study indicated that patients who received radiation 30 days or fewer before their CAR T-cell infusion did not experience serious cytokine release syndrome or neurotoxicity.

Mammography found more effective at detecting breast cancer in men with high risk than for women with an average risk and in detecting the disease before it metastasizes.

Study participants who consumed approximately 500 mg of total flavonoids each day had the lowest risk of a cancer or heart disease-related death.

Study shows that higher levels of PTSD symptoms can be associated with increased risks of ovarian cancer even decades after women experience a traumatic event.

The report is the result of collaboration among experts across the agency and incorporates important input from patients, researchers, and advocates.

Transplanting organ from patients infected with hepatitis C could greatly expand the number of kidneys available and reduce wait times.

New approach involves treating patients with a high dose factor VIII concentrates along with emicizumab, a modification of the standard immune tolerance induction.

Study finds association between obesity and a greater burden of symptoms and distress among patients with breast or prostate cancer.

Building on the current understanding of spihingosine 1-phosphate levels in regulating T cell function, researchers found that the inhibition of the lipid can lead to more effective uses of immunotherapy in cancer therapy.

The individual had recently vaped and was hospitalized after developing complications from a severe respiratory illness.

Selinexor with dexamethasone effective in more than one-quarter of patients with multiple myeloma during a clinical trial.

Patients with progressive multiple sclerosis who were placed on the Wahls diet, which is high in fruits and vegetables, found to experience improved fatigue levels.

The results of a study of almost 500,000 women indicate that taking paracetamol or other painkillers during pregnancy does not increase the risk of asthma in children.

Direct-to-consumer prescription drug advertising increased from $1.3 billion to $6 billion over the past 20 years, particularly for high-cost biologics and cancer immunotherapies.

Combination of ibrutinib and rituximab found to improve overall survival in patients with chronic lymphocytic leukemia.

Novel process may identify cancer metastasis at an earlier stage when it may be easier to treat.

Research highlights the importance of regular blood testing to impove earlier detection of multiple myeloma.

Aspirin therapy found to improve liver function test results and survival after transarterial embolization for hepatocellular carcinoma.

Study recommends similar clinical thresholds for diagnosing and managing giant cell arteritis for patients of different ethnicities.

High body mass index is associated with an increased risk of chronic diseases such as type 2 diabetes, cancer, musculoskeletal, and respiratory conditions.

Artificial intelligence able to recognize patterns in gene sequences and molecular data from breast cancer, which oncologists are now evaluating in clinical trials.

By searching for hyperactive cell signals in primary effusion lymphoma, researchers were able to find a pathway that can be blocked to limit tumor growth.

A regimen of afatinib as a first-line treatment followed by osimertinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer was found to significantly improve overall survival.

Identifying gene-pair relationships may help scientists understand why mutations in certain genes lead to cancer in certain tissues.

Research could lead to the development of new cancer treatments to stop tumor growth.

About 1000 patients are helped each month to reduce their costs for medications through the initiative.

Darolutamide is an androgen receptor inhibitor (ARi) for the treatment of patients with non-metastatic castration-resistant prostate cancer.

Panel members provide information on HE and its symptoms, precipitants, and treatment.

Darolutamide, an androgen receptor inhibitor (ARi) for the treatment of patients with non-metastatic castration-resistant prostate cancer, was approved by the FDA this week.

In a study by Johns Hopkins Medicine, investigators used an advanced form of brain scan to demonstrate that 12 participants in their study with documented posttreatment Lyme disease syndrom (PTLDS) all showed elevation of a chemical marker of wide-spread brain inflammation compared with 19 controls.